PAFerroptosis Combined with Metabolic Disturbance of Mito by p52‐ZER6 for Enhanced Cancer Immunotherapy induced by Nano‐Bacilliform‐Enzyme
Advanced Healthcare Materials · 2024
DOI: 10.1002/adhm.202402314 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2024. Verfasst von Zi-Yue Xi und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, 110016, China. Hauptthemen laut MEDLINE: Mitochondria, Immunotherapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 69 Literaturangaben. Gefördert von: Research Project of Department of Education of Liaoning Province.
Abstract (Originalsprache)
The confused gene expressions and molecular mechanisms for mitochondrial dysfunction of traditional nanoenzymes is a challenge for tumor therapy. Herein, a nano‐bacilliform‐enzyme obtains the ability to inhibit p52‐ZER6 signal pathway, regulate the genes related to mitochondrial metabolism, and possess the GOx/CAT/POD‐like property. NBE acquires catalytic activity from the electronic energy transition. The tannin of NBE as a mitochondrial (Mito)‐targeting guide overloads MitoROS, and then metabolic disorder and lipid peroxidation of Mito membrane occurs, thus leading to a novel death pathway called PAFerroptosis (pyroptosis, apoptosis, and Ferroptosis). Simultaneously, in order to refrain from mitophagy, hydroxychloroquine is mixed with NBE to form a combo with strength pyroptosis. As a result, NBE/combo improves the PAFerroptosis obviously by activation of CD8+T cells and inactivation of MDSC cells, up‐regulating expression of caspase‐3 signal pathway, intercepting DHODH pathway to arrive excellent antitumor effect (93%). Therefore, this study establishes a rational nanoenzyme for mitochondrial dysfunction without mitophagy for effective antitumor therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, 110016, China.
ORCID-Profile: Lu Xu
Förderung
- Research Project of Department of Education of Liaoning Province
Zitieren
APA
Xi, Z. Y., Fan, C. Y., Zhu, S., Nie, G. Y., Xi, X. R., Jiang, Y. Y., Zhou, Y., Mei, Y. H., & Xu, L. (2024). PAFerroptosis Combined with Metabolic Disturbance of Mito by p52‐ZER6 for Enhanced Cancer Immunotherapy induced by Nano‐Bacilliform‐Enzyme. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202402314
Vancouver
Xi ZY, Fan CY, Zhu S, Nie GY, Xi XR, Jiang YY, et al. PAFerroptosis Combined with Metabolic Disturbance of Mito by p52‐ZER6 for Enhanced Cancer Immunotherapy induced by Nano‐Bacilliform‐Enzyme. Advanced Healthcare Materials. 2024. doi:10.1002/adhm.202402314
BibTeX
@article{Xi2024,
author = {Xi, Zi-Yue and Fan, Chuan-Yong and Zhu, Shuang and Nie, Gan-Yu and Xi, Xin-Ran and Jiang, Ying-Ying and Zhou, Yao and Mei, Yi-Hua and Xu, Lu},
title = {PAFerroptosis Combined with Metabolic Disturbance of Mito by p52‐ZER6 for Enhanced Cancer Immunotherapy induced by Nano‐Bacilliform‐Enzyme},
journal = {Advanced Healthcare Materials},
year = {2024},
doi = {10.1002/adhm.202402314}
}
EUVIMED